Literature DB >> 10463048

Evaluating the impact of reference-based pricing.

P Grootendorst, A Holbrook.   

Abstract

Mesh：

Year:  1999        PMID： 10463048      PMCID： PMC1230503     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia.

Authors:  John K Marshall; Paul V Grootendorst; Bernie J O'Brien; Lisa R Dolovich; Anne M Holbrook; Adrian R Levy
Journal:  CMAJ       Date:  2002-06-25       Impact factor: 8.262

2.  The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.

Authors:  Steve Morgan; Colleen Cunningham
Journal:  Healthc Policy       Date:  2008-02

3.  The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.

Authors:  Steve Morgan; Colleen Cunningham
Journal:  Healthc Policy       Date:  2008-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.